On July 14th 2021, a National Patient Safety Alert was issued by NHS England relating to choice of anticoagulant drugs prescribed to patients with mechanical heart valves.1 This was triggered by cases presenting to hospital of patients that had been switched from anticoagulation with warfarin to a
BHVS June 2021 Newsletter
Caution required before extending TAVI to younger patients?
Recently, BHVS President Dr Benoy Shah was invited to comment on an upcoming review article due to be published in JACC Intervention regarding TAVI in younger patients. The article set out in a systematic fashion the challenges and unknowns for TAVI in this patient population before presenting data
Getting the best from the Heart Team: Guidance for the structure and function of cardiac multidisciplinary meetings
The British Heart Valve Society was delighted to collaborate with the British Cardiovascular Society (BCS), British Cardiovascular Intervention Society (BCIS), Society for Cardiothoracic Surgery (SCTS) and Association for Cardiothoracic Anaesthesia and Critical Care (ACTACC) on the creation and
BHVS AGM 2020
Click to Register for the BHVS 2020 AGM
COVID-19 / CORONAVIRUS ILLNESS and HEART VALVE DISEASE
A POSITION STATEMENT FOR PATIENTS FROM THE BRITISH HEART VALVE SOCIETY Am I high risk? People with heart disease are at higher risk from Covid-19 but no information specifically for valve disease exists. It is likely that mild or moderate valve disease does not increase the risk. This
BHVS on MedShr
BHVS Young Investigators Awards 7th and 8th November 2019
The BHVS is eager to encourage young researchers working on all aspects of research related to heart valves and heart valve disease. As part of this initiative, the Society will host its sixth Young Investigators Session during the forthcoming Annual Meeting which will be held at the British Heart